These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 39228142)

  • 1. Exploring the interplay between bisphenol A exposure, the immune microenvironment and hepatocellular carcinoma progression.
    Liu Q; Niu R; Ye Y; Li J
    J Gene Med; 2024 Sep; 26(9):e3723. PubMed ID: 39228142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of PANoptosis-related subtypes, construction of a prognosis signature, and tumor microenvironment landscape of hepatocellular carcinoma using bioinformatic analysis and experimental verification.
    Ouyang G; Li Q; Wei Y; Dai W; Deng H; Liu Y; Li J; Li M; Luo S; Li S; Liang Y; Pan G; Yang J; Gan T
    Front Immunol; 2024; 15():1323199. PubMed ID: 38742112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastasis and basement membrane-related signature enhances hepatocellular carcinoma prognosis and diagnosis by integrating single-cell RNA sequencing analysis and immune microenvironment assessment.
    Wei S; Tan J; Huang X; Zhuang K; Qiu W; Chen M; Ye X; Wu M
    J Transl Med; 2024 Jul; 22(1):711. PubMed ID: 39085893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune- and metabolism-related gene signature analysis uncovers the prognostic and immune microenvironments of hepatocellular carcinoma.
    Gu Y; Ma E; Jiang S; Shan Z; Xia G; Ma R; Fu J; Wang Z
    J Cancer Res Clin Oncol; 2024 Jun; 150(6):311. PubMed ID: 38896142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.
    Zhang FP; Huang YP; Luo WX; Deng WY; Liu CQ; Xu LB; Liu C
    World J Gastroenterol; 2020 Jan; 26(2):134-153. PubMed ID: 31969776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct cuproptosis patterns in hepatocellular carcinoma patients correlate with unique immune microenvironment characteristics and cell-cell communication, contributing to varied overall survival outcomes.
    Wang Y; Mang X; Guo X; Pu J
    Front Immunol; 2024; 15():1379690. PubMed ID: 38868777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B-cell-specific signatures reveal novel immunophenotyping and therapeutic targets for hepatocellular carcinoma.
    Xu KQ; Gong Z; Yang JL; Xia CQ; Zhao JY; Chen X
    World J Gastroenterol; 2024 Sep; 30(34):3894-3925. PubMed ID: 39350784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elucidating the multifaceted role of MGAT1 in hepatocellular carcinoma: integrative single-cell and spatial transcriptomics reveal novel therapeutic insights.
    Li Y; Chen Y; Wang D; Wu L; Li T; An N; Yang H
    Front Immunol; 2024; 15():1442722. PubMed ID: 39081317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel super-enhancer-related risk model for predicting prognosis and guiding personalized treatment in hepatocellular carcinoma.
    Wu Q; Li P; Tao X; Lin N; Mao B; Xie X
    BMC Cancer; 2024 Sep; 24(1):1087. PubMed ID: 39223584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role and Clinical Relevance of Glycolysis-Associated Genes on Immune Infiltration in Hepatocellular Carcinoma.
    Li J; Su P; Li T; Hao Y; Wang T; Fu L; Liu X
    J Cell Biochem; 2024 Aug; 125(8):e30620. PubMed ID: 38923014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-driven lncRNA CTD-2510F5.4: a potential player in hepatocellular carcinoma's prognostic stratification, cellular behavior, tumor microenvironment, and therapeutic response.
    Abulihaiti Z; Li W; Yang L; Zhang H; Du A; Tang N; Lu Y; Zeng J
    Mol Biol Rep; 2024 Aug; 51(1):905. PubMed ID: 39133347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of LOXL3-associating immune infiltration landscape and prognostic value in hepatocellular carcinoma.
    Wang N; Zhou X; Tang F; Wang X; Zhu X
    Virchows Arch; 2021 Dec; 479(6):1153-1165. PubMed ID: 34448895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.
    Xiang S; Li J; Shen J; Zhao Y; Wu X; Li M; Yang X; Kaboli PJ; Du F; Zheng Y; Wen Q; Cho CH; Yi T; Xiao Z
    Front Immunol; 2021; 12():653836. PubMed ID: 33897701
    [No Abstract]   [Full Text] [Related]  

  • 14. Predictive value of a stemness-based classifier for prognosis and immunotherapy response of hepatocellular carcinoma based on bioinformatics and machine-learning strategies.
    Chen E; Zou Z; Wang R; Liu J; Peng Z; Gan Z; Lin Z; Liu J
    Front Immunol; 2024; 15():1244392. PubMed ID: 38694506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analysis of prognostic immune-related genes in the tumor microenvironment of hepatocellular carcinoma (HCC).
    Li M; Li H; Zhou C; Li X; Gong J; Chen C; Zhang Y
    Medicine (Baltimore); 2021 Oct; 100(39):e27332. PubMed ID: 34596136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HMGB2 drives tumor progression and shapes the immunosuppressive microenvironment in hepatocellular carcinoma: insights from multi-omics analysis.
    Chen YZ; Meng ZS; Xiang ZL
    Front Immunol; 2024; 15():1415435. PubMed ID: 39247201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unraveling the role of ADAMs in clinical heterogeneity and the immune microenvironment of hepatocellular carcinoma: insights from single-cell, spatial transcriptomics, and bulk RNA sequencing.
    Chen J; Yuan Q; Guan H; Cui Y; Fu C; Wei T; Liu K
    Front Immunol; 2024; 15():1461424. PubMed ID: 39346916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive Pan-Cancer Genomic Analysis Reveals PHF19 as a Carcinogenic Indicator Related to Immune Infiltration and Prognosis of Hepatocellular Carcinoma.
    Zhu ZY; Tang N; Wang MF; Zhou JC; Wang JL; Ren HZ; Shi XL
    Front Immunol; 2021; 12():781087. PubMed ID: 35069553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic values of immune scores and immune microenvironment-related genes for hepatocellular carcinoma.
    Ge PL; Li SF; Wang WW; Li CB; Fu YB; Feng ZK; Li L; Zhang G; Gao ZQ; Dang XW; Wu Y
    Aging (Albany NY); 2020 Mar; 12(6):5479-5499. PubMed ID: 32213661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histamine-related genes participate in the establishment of an immunosuppressive microenvironment and impact the immunotherapy response in hepatocellular carcinoma.
    Zhang X; Zheng P; Meng B; Zhuang H; Lu B; Yao J; Han F; Luo S
    Clin Exp Med; 2024 Jun; 24(1):129. PubMed ID: 38884870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.